Your browser is no longer supported. Please, upgrade your browser.
Settings
AVEO AVEO Pharmaceuticals, Inc. daily Stock Chart
AVEO [NASD]
AVEO Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.20 Insider Own0.30% Shs Outstand126.61M Perf Week-1.69%
Market Cap73.45M Forward P/E- EPS next Y-0.26 Insider Trans- Shs Float124.90M Perf Month-7.76%
Income-23.60M PEG- EPS next Q-0.05 Inst Own41.90% Short Float14.30% Perf Quarter-66.27%
Sales4.00M P/S18.36 EPS this Y-475.00% Inst Trans-0.53% Short Ratio4.86 Perf Half Y-79.79%
Book/sh-0.22 P/B- EPS next Y-13.00% ROA- Target Price1.75 Perf Year-80.66%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.49 - 3.59 Perf YTD-63.74%
Dividend- P/FCF- EPS past 5Y- ROI313.00% 52W High-83.84% Beta1.10
Dividend %- Quick Ratio1.50 Sales past 5Y33.10% Gross Margin- 52W Low18.24% ATR0.04
Employees19 Current Ratio1.50 Sales Q/Q1708.50% Oper. Margin- RSI (14)30.81 Volatility6.33% 7.35%
OptionableYes Debt/Eq- EPS Q/Q523.50% Profit Margin- Rel Volume0.56 Prev Close0.62
ShortableYes LT Debt/Eq- EarningsMar 26 BMO Payout- Avg Volume3.68M Price0.58
Recom2.30 SMA20-0.44% SMA50-41.04% SMA200-71.14% Volume2,072,345 Change-6.65%
Feb-04-19Downgrade B. Riley FBR Buy → Neutral $5 → $1
Feb-01-19Downgrade H.C. Wainwright Buy → Neutral $1
Jan-04-19Initiated Robert W. Baird Outperform
Nov-13-17Initiated B. Riley FBR, Inc. Buy $5
May-19-16Initiated Piper Jaffray Overweight $1.70
Mar-30-16Initiated FBR Capital Outperform $3
Mar-09-15Upgrade RBC Capital Mkts Underperform → Sector Perform $2 → $3
Dec-16-13Downgrade RBC Capital Mkts Sector Perform → Underperform $5 → $2
May-03-13Upgrade Stifel Sell → Hold
May-03-13Downgrade RBC Capital Mkts Outperform → Sector Perform $15 → $6
May-03-13Downgrade Canaccord Genuity Buy → Hold $2
Dec-21-12Reiterated RBC Capital Mkts Outperform $18 → $15
Nov-14-12Initiated Stifel Nicolaus Sell
May-04-12Reiterated RBC Capital Mkts Outperform $24 → $19
May-13-11Upgrade MP Advisors Underperform → Market Perform $11 → $20
Nov-30-10Initiated RBC Capital Mkts Outperform $24
Nov-29-10Initiated MP Advisors Underperform $8
Mar-22-19 03:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, CTL and MBT ACCESSWIRE -6.65%
02:13PM  Lifshitz & Miller LLP Announces Investigation of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., Spark Therapeutics, Inc., Stamps.com, Inc., Syneos Health, Inc., and Weight Watchers, Inc. PR Newswire
10:40AM  SHAREHOLDER ALERT: MU SVXY AVEO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Mar-21-19 06:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO GlobeNewswire
10:26AM  CLASS ACTION UPDATE for AVEO, STMP, AMR and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Mar-20-19 08:54PM  DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. AVEO GlobeNewswire
03:00PM  HIIQ, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC Class Action Reminder GlobeNewswire
10:55AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASTE, AVEO and NIO ACCESSWIRE
09:53AM  HIIQ, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
09:42AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SPB, ASTE, VALE and AVEO GlobeNewswire
Mar-19-19 07:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
12:04PM  AVEO (AVEO) Upgraded to Buy: What Does It Mean for the Stock? Zacks
10:37AM  SHAREHOLDER ALERT: ASTE AVEO STMP CAG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
09:52AM  HIIQ, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Mar-17-19 10:29AM  CLASS ACTION UPDATE for AVEO, MHLD and NIO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
08:29AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
Mar-16-19 05:23PM  AVEO INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. AVEO GlobeNewswire
Mar-15-19 03:45PM  CLASS ACTION UPDATE for MAXR, UXIN and AVEO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:59PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:38AM  AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat, Revenues Lag Zacks
11:29AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZIV, UXIN, AVEO and GE GlobeNewswire
05:12AM  AVEO: 4Q Earnings Snapshot Associated Press
Mar-14-19 09:32PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  AVEO GlobeNewswire
04:05PM  AVEO Reports Full Year 2018 Financial Results and Provides Business Update Business Wire
03:40PM  FILING DEADLINE-Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DBVT, ASTE and AVEO ACCESSWIRE
03:00PM  Class Action Update KHC, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
01:00PM  SHAREHOLDER ALERT: DBVT UXIN AVEO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:22AM  (AVEO) AVEO Pharmaceuticals, Inc. Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Deadline: April 26, 2019 ACCESSWIRE
Mar-13-19 03:28PM  CLASS ACTION UPDATE for TYME, AVEO, CVS and CTL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:22AM  (AVEO) AVEO Pharmaceuticals, Inc. Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Final Deadline: April 26, 2019 ACCESSWIRE
10:03AM  SHAREHOLDER ALERT: ARLO UXIN AVEO MHLD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Mar-12-19 09:35PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
08:50PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
04:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MAXR, AVEO, AMRN and CVS GlobeNewswire
03:37PM  AVEO DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against AVEO Pharmaceuticals Inc. AVEO GlobeNewswire
10:20AM  KHC, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
Mar-11-19 06:47PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of AVEO Pharmaceuticals, Inc. Investors GlobeNewswire +8.67%
Mar-10-19 10:00AM  CLASS ACTION UPDATE for GSM, AVEO and KHC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Mar-08-19 04:52PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of AVEO Pharmaceuticals, Inc. Investors GlobeNewswire
04:25PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DBVT, TYME and AVEO ACCESSWIRE
12:00PM  (AVEO) AVEO Pharmaceuticals, Inc. Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Final Deadline: April 26, 2019 GlobeNewswire
09:00AM  CLASS ACTION UPDATE for DBVT, ATVI and AVEO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Mar-07-19 07:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline  AVEO GlobeNewswire
07:06PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of AVEO Pharmaceuticals, Inc. Investors Business Wire
06:48PM  AVEO INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. - AVEO PR Newswire
04:10PM  AVEO PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against AVEO Pharmaceuticals, Inc. GlobeNewswire
Mar-06-19 10:27AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNKEY, UXIN, AVEO and TAP GlobeNewswire
Mar-05-19 10:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
06:15PM  RM LAW Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. PR Newswire
01:52PM  SHAREHOLDER ALERT: ZIV AVEO SYNH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Mar-04-19 06:05PM  Robbins Arroyo LLP: AVEO Pharmaceuticals, Inc. (AVEO) Sued for Misleading Shareholders Business Wire
04:54PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of AVEO Pharmaceuticals, Inc. Investors Business Wire
04:08PM  AVEO ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against AVEO Pharmaceuticals Inc. AVEO GlobeNewswire
12:32PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Deadline: April 26, 2019 ACCESSWIRE
11:36AM  SHAREHOLDER ALERT: AVEO KHC STMP SYNH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:29AM  Class Action Reminder KHC, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Mar-03-19 06:20PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Diplomat Pharmacy, Vanda Pharmaceuticals, and AVEO Pharmaceuticals and Encourages Investors to Contact the Firm GlobeNewswire
05:25PM  Class Action Update KHC, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
08:35AM  AVEO INVESTOR ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action Lawsuit AVEO Business Wire
Mar-01-19 03:55PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. AVEO GlobeNewswire +5.49%
01:26PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
12:00PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, STMP and DPLO GlobeNewswire
Feb-28-19 03:11PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Deadline: April 26, 2019 ACCESSWIRE -11.85%
12:39PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YRCW, PRGO, AVEO and CVS GlobeNewswire
12:10PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: April 26, 2019 ACCESSWIRE
10:00AM  Class Action Update HIIQ, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Feb-27-19 04:05PM  AVEO PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against AVEO Pharmaceuticals, Inc. GlobeNewswire
03:32PM  CLASS ACTION UPDATE for MU, AVEO, DPLO and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:10PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Notifies of Class Action and Lead Deadline: April 26, 2019 ACCESSWIRE
02:24PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:51PM  CLASS ACTION UPDATE for ARLO, GSM, SVXY and AVEO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:09PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Notifies of Class Action and Deadline: April 26, 2019 ACCESSWIRE
09:59AM  Class Action HIIQ, AVEO & CVS Bronstein, Gewirtz & Grossman, LLC Update ACCESSWIRE
09:29AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, MHLD, KHC and AMRN GlobeNewswire
Feb-26-19 10:46PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
08:18PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors to Contact the Firm GlobeNewswire
07:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
04:05PM  AVEO Oncology Announces Appointment of Gregory T. Mayes to its Board of Directors Business Wire
04:02PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: April 26, 2019 ACCESSWIRE
03:45PM  AVEO Pharmaceuticals, Inc. (AVEO) Bronstein, Gewirtz & Grossman, LLC Notifies of Class Action and Lead Plaintiff Deadline: April 26, 2019 ACCESSWIRE
02:39PM  CLASS ACTION UPDATE for AVEO, GE, MHLD and CVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-25-19 09:12PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. AVEO Business Wire +5.76%
07:49PM  Pomerantz Law Firm Announces the Filing of a Class Action against Aveo Pharmaceuticals, Inc. and Certain Officers AVEO GlobeNewswire
Feb-21-19 01:35PM  Four Biotech Stocks Setting The Standard On Thursday (2/21/19) ACCESSWIRE
07:55AM  Investor Expectations to Drive Momentum within Sangamo Therapeutics, AVEO Pharmaceuticals, Everbridge, Huntington Ingalls Industries, Woodward, and SAP SE Discovering Underlying Factors of Influence GlobeNewswire
Feb-20-19 07:00AM  AVEO Oncology to Present at the 8th Annual SVB Leerink Global Healthcare Conference Business Wire -9.45%
Feb-16-19 01:00PM  AVEO Oncology Announces Oral Presentation of TIVO-3 Trial Topline Results at the 2019 ASCO Genitourinary Cancers Symposium Business Wire
Feb-07-19 09:39AM  The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO Zacks -5.21%
Feb-06-19 07:06AM  Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink Zacks
Feb-03-19 04:00PM  Bragar Eagel & Squire, P.C. is Investigating AVEO Pharmaceuticals, Inc. (AVEO) on Behalf of Stockholders and Encourages AVEO Investors to Contact the Firm GlobeNewswire
Feb-01-19 10:49AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of AVEO Pharmaceuticals, Inc. GlobeNewswire -14.20%
10:07AM  AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA Zacks
Jan-31-19 01:04PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AVEO Pharmaceuticals, Inc. (AVEO) GlobeNewswire -60.49%
12:12PM  Why AVEO Oncology Stock Is Crashing Today Motley Fool
11:01AM  Aveo stock plunges after delay in FDA approval submission for cancer drug American City Business Journals
09:00AM  AVEO Oncology Announces NDA Timing Update Business Wire
Jan-28-19 07:45AM  Report: Exploring Fundamental Drivers Behind Realty Income, United Therapeutics, NxStage Medical, PTC Therapeutics, AVEO Pharmaceuticals, and Owens & Minor New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-23-19 08:48AM  Options Traders Expect Huge Moves in AVEO Pharmaceuticals (AVEO) Stock Zacks
Jan-17-19 05:14AM  How to spot risky biotech companies and six to avoid now MarketWatch
Jan-10-19 10:49AM  Here's Why These Small-Cap Pharma Stocks Lost as Much as 45% in December Motley Fool
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical need. It markets its lead candidate, tivozanib, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC). The company has also completed a Phase 3 TIVO-3 trial of tivozanib for the treatment of advanced RCC; and initiated enrollment in a phase Ib/II clinical trial of tivozanib in combination with Opdivo (nivolumab), an immune checkpoint (PD-1) inhibitor, for the treatment of advanced RCC. In addition, it is developing Ficlatuzumab, a potent hepatocyte growth factor inhibitory antibody, in Phase I and Phase II clinical trials in squamous cell carcinoma of the head and neck, metastatic pancreatic ductal cancer, and acute myeloid leukemia; and AV-203, a potent anti-ErbB3 specific monoclonal antibody, which has completed Phase I clinical trial for treating esophageal cancer. The company's preclinical stage products include AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; and AV-353 for the treatment of pulmonary arterial hypertension. It has strategic partnerships with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec; and Kyowa Hakko Kirin Co., Ltd. AVEO Pharmaceuticals, Inc. has a clinical collaboration with AstraZeneca PLC to evaluate IMFINZI (durvalumab), a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is based in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARRIS PETER J10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:16 PM
Growth Equity Opportunities IV10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:15 PM
Florence Anthony A. Jr.10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:17 PM
BASKETT FOREST10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:16 PM
MAKOWER JOSHUA10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:18 PM
Makhzoumi Mohamad10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:17 PM
SANDELL SCOTT D10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:18 PM
MOTT DAVID M10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:18 PM
Sonsini Peter W.10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:19 PM
BARRIS PETER J10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:16 PM
Growth Equity Opportunities IV10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:15 PM
Florence Anthony A. Jr.10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:17 PM
BASKETT FOREST10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:16 PM
MAKOWER JOSHUA10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:18 PM
Makhzoumi Mohamad10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:17 PM
SANDELL SCOTT D10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:18 PM
MOTT DAVID M10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:18 PM
Sonsini Peter W.10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:19 PM
Florence Anthony A. Jr.10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:41 PM
BASKETT FOREST10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:41 PM
BARRIS PETER J10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:41 PM
Growth Equity Opportunities IV10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:40 PM
MAKOWER JOSHUA10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:42 PM
Makhzoumi Mohamad10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:42 PM
SANDELL SCOTT D10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:43 PM
MOTT DAVID M10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:43 PM
Sonsini Peter W.10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:44 PM
Growth Equity Opportunities IV10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:18 PM
BASKETT FOREST10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:19 PM
BARRIS PETER J10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:19 PM
Makhzoumi Mohamad10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:20 PM
Florence Anthony A. Jr.10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:20 PM
MAKOWER JOSHUA10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:21 PM
SANDELL SCOTT D10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:23 PM
MOTT DAVID M10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:22 PM
Sonsini Peter W.10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:23 PM
Growth Equity Opportunities IV10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:18 PM
BASKETT FOREST10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:19 PM
BARRIS PETER J10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:19 PM
Makhzoumi Mohamad10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:20 PM
Florence Anthony A. Jr.10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:20 PM
MAKOWER JOSHUA10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:21 PM
SANDELL SCOTT D10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:23 PM
MOTT DAVID M10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:22 PM
Sonsini Peter W.10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:23 PM
Growth Equity Opportunities IV10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:18 PM
BASKETT FOREST10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:19 PM
BARRIS PETER J10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:19 PM
Makhzoumi Mohamad10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:20 PM
Florence Anthony A. Jr.10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:20 PM
MAKOWER JOSHUA10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:21 PM
SANDELL SCOTT D10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:23 PM
MOTT DAVID M10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:22 PM
Sonsini Peter W.10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:23 PM
Growth Equity Opportunities IV10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:10 PM
BASKETT FOREST10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:11 PM
BARRIS PETER J10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:10 PM
Makhzoumi Mohamad10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:12 PM
Florence Anthony A. Jr.10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:11 PM
MOTT DAVID M10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:13 PM
MAKOWER JOSHUA10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:12 PM
Sonsini Peter W.10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:14 PM
SANDELL SCOTT D10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:13 PM
Growth Equity Opportunities IV10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:10 PM
BASKETT FOREST10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:11 PM
BARRIS PETER J10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:10 PM
Makhzoumi Mohamad10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:12 PM
Florence Anthony A. Jr.10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:11 PM
MOTT DAVID M10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:13 PM
MAKOWER JOSHUA10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:12 PM
Sonsini Peter W.10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:14 PM
SANDELL SCOTT D10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:13 PM
EVNIN ANTHONY BDirectorNov 21Buy2.05109223109Nov 26 04:58 PM
Sonsini Peter W.10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:42 PM
Growth Equity Opportunities IV10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:41 PM
BASKETT FOREST10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:44 PM
Florence Anthony A. Jr.10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:44 PM
Makhzoumi Mohamad10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:43 PM
MAKOWER JOSHUA10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:43 PM
MOTT DAVID M10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:42 PM
SANDELL SCOTT D10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:42 PM
BARRIS PETER J10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:44 PM
BASKETT FOREST10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:40 PM
BARRIS PETER J10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:40 PM
Growth Equity Opportunities IV10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:39 PM
Florence Anthony A. Jr.10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:41 PM
MAKOWER JOSHUA10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:42 PM
Makhzoumi Mohamad10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:41 PM
SANDELL SCOTT D10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:44 PM
MOTT DAVID M10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:44 PM
Sonsini Peter W.10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:45 PM
BASKETT FOREST10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:40 PM
BARRIS PETER J10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:40 PM
Growth Equity Opportunities IV10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:39 PM
Florence Anthony A. Jr.10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:41 PM
MAKOWER JOSHUA10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:42 PM
Makhzoumi Mohamad10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:41 PM
SANDELL SCOTT D10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:44 PM
MOTT DAVID M10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:44 PM
Sonsini Peter W.10% OwnerNov 16Buy1.86350,000649,35519,388,038Nov 19 07:45 PM